J-ARM

J-ARM is a Japanese veterinary regenerative medicine company focused on helping animal hospitals introduce and use cell-based therapies for dogs and cats. The company provides cell culture training, protocol transfer, culture kits, cell characterization, and safety testing to support physician-led veterinary use of activated lymphocyte therapies, dendritic cell approaches, NK cell culture, and adipose-derived stem cell therapies. Its business is service- and platform-oriented rather than centered on conventional drug commercialization, with offerings designed to enable regenerative medicine in veterinary clinics under Japan's regulatory framework. J-ARM has reported work and case-based evidence in companion animal oncology and degenerative diseases, including feline osteoarthritis and canine cancers. The company has also partnered with Rohto Pharmaceutical to develop higher-function cell culture kits and new veterinary regenerative medicine services.